Indivior Pharmaceuticals Inc (INDV) Stock Score, Valuation & Financial Research
Indivior Pharmaceuticals Inc is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 53/100.
Quick answer for INDV
Indivior Pharmaceuticals Inc currently has a Wall Street Score of 53/100. The stored market price is $34.35. Its financial score is 47/100. Its valuation score is 97/100. These figures are a research snapshot, not a buy or sell recommendation.
What Indivior Pharmaceuticals Inc does
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
INDV financial snapshot
- Wall Street Score:
- 53/100
- Current price:
- $34.35
- Market capitalization:
- $4.29B
- Revenue:
- $1.33B
- Net income:
- $355.0M
- Free cash flow:
- $-94.0M
- Cash:
- $222.0M
- Total debt:
- $509.0M
- EPS:
- 2.84
- P/E ratio:
- 12.1x
- Financial score:
- 47/100
- Valuation score:
- 97/100
- Revenue score:
- 35/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-94.0M, showing cash burn in the current stored period.
- The balance sheet shows $222.0M of cash versus $509.0M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 97/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 47/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research INDV
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.